Category: General

Exicure’s science may be complicated to the lay person but their successes are easy to admire. Way to go to the great leadership team and researchers at Exicure for witnessing your success as a company warrant being listed on the Russell 3000^R index. Your investors are excited about your accomplishments from a financial as well as a scientific stand point.

Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure’s proprietary spherical nucleic acid (SNA™) architecture is designed to unlock the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure’s lead programs address inflammatory diseases, genetic disorders and oncology.”

Congratulations to the team at Genprex as their company is now listed on the Russell 3000^R index! This is an exciting step forward for the company’s health. We at Bear Creek Capital wish you all continued success with your scientific breakthroughs to help patients with cancer and diabetes.

Congratulations to the team at NeuBase for being listed on the Russell 3000^R index. Bear Creek Capital is proud to have been associated with your great leadership team. We not only believe in your mission, but we believe in the quality of the people you have assembled to lead you forward.

NeuBase Therapeutics, Inc., is developing the next generation of gene silencing therapies with its flexible, highly specific synthetic antisense oligonucleotides.”

Huh, you ask? What that means in simpler terms is that their proprietary platform allows them to develop “targeted drugs, increasing the treatment opportunities for the hundreds of millions of people affected by rare genetic diseases, including those that can only be treated through accessing of secondary RNA structures.”

Congratulations to NeuBase Therapeutics, Genprex, and Exicure for their 2020 accomplishments. Despite all the disruptions the Coronavirus unleashed on the world, as of June 2020 these three client companies are all now listed on the Russell 3000^R index. Never losing focus, strong research and leadership teams are making a difference.

Bear Creek Capital has worked with more than 100 public companies. It is still a thrill to witness successes; to be able to share the sense of accomplishment. Each of these companies are striving to better the lives and health of people worldwide. Thanks to each of you for never dropping the ball, for remaining focused on your goals, for making your investors proud to be a part of your accomplishments.

NeuBase Therapeutics, Inc.
NBSE on Nasdaq

Genprex, Inc.
GNPX on Nasdaq

Exicure, Inc.
XCUR on Nasdaq

[For release: 2020/09-10]. Bear Creek Capital is happy to announce it has a new online presence today. We’ve given bearcreekcapital.com a face lift to better reflect our services and enthusiasm for small companies looking to drive sales through key relationships.

As Bear Creek’s CEO, I am well aware of the struggle to grow business while conducting business. Just as I sought technical help to create this new website and automate my business, I bring my experience and enthusiasm to help grow other businesses. Every day I just need to select a hat …..